OTC · Biotechnology

Bionomics Limited (BNOEF) Stock

$0.01 -14.89% OTC: BNOEF Healthcare

Bionomics Limited, an Australian clinical-stage biopharmaceutical company founded in 1996 and based in Eastwood, focuses on identifying and developing innovative drug candidates to address central nervous system conditions and various cancers. A significant experimental medicine in their pipeline is BNC210, a negative allosteric modulator targeting the a7 nicotinic acetylcholine receptor.

Valuation

MetricValue
Price$0.01
Market Cap$8.81M
P/E Ratio-0.30
P/B Ratio0.61
P/S Ratio-1.72
EPS (TTM)$-0.01
52-Week High$0.06
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-113.35%
ROA-81.82%
ROCE-72.57%
Gross Margin104.75%
Operating Margin230.73%
Net Margin271.97%
Debt/Equity0.00
Current Ratio14.31

Annual Financials (USD)

Metric20192020202120222023
Revenue$3.0M$1.0M$0$1.0M$0
Operating Profit$-7.0M$-10.0M$-18.0M$-22.0M$-17.9B
Net Profit$-5.0M$-9.0M$-15.0M$-21.0M$-15.5B
EPS$-1.92$-2.01$-3.62$-3.60$-0.01
Op Margin-250.2%-1107.3%-6699.5%-3310.8%—

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$24.0M$41.0M$45.0M$29.0M$28.0M
Total Liabilities$15.0M$5.0M$6.0M$7.0M$10.0M
Cash$3.0M$21.0M$23.0M$12.0M$13.0M
Borrowings$8.0M$1.0M$0$0$0

Latest News

Hyundai Motor reports 21% drop in Q2 operating profit, misses forecasts Reuters · Jul 23, 2026 Asian stocks rise as AI capex ramps up, oil at six-week highs Reuters · Jul 23, 2026 TenPay Global Named to CNBC's World's Top Fintech Companies 2026 List PR Newswire · Jul 23, 2026 Besi posts sharp rise in quarterly orders Reuters · Jul 23, 2026 Nokia provides recast comparative financial information reflecting the presentation of Fixed Wireless Access CPE and Enterprise Campus Edge businesses as discontinued operations GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-3.0M$-6.0M$-15.0M$-14.0M$-15.0M
Investing Cash Flow$0$0$1.0M$0$0
Financing Cash Flow$0$0$4.0M$0$5.0M
Net Cash Flow$-7.0M$18.0M$5.0M$-11.0M$1.0M
Free Cash Flow$-3.0M$-6.0M$-15.0M$-14.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA0.06
FCF Yield330.41%
Quick Ratio14.31
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EIGRQEiger BioPharmaceuticals, Inc. $8.50 +6.25% -0.17 $12.59M 0.00%
FLWPFThe Flowr Corporation $0.00 — — $4265 0.00%
FWPAYForward Pharma A/S $300.00 -25.09% 2166.67 $7.45M 0.00%
HBCNFHealthBeacon plc $0.50 +2269.67% -0.55 $8.44M 0.00%
IMUNImmune Therapeutics, Inc. $0.09 -7.00% -0.56 $7.78M 0.00%

About Bionomics Limited

Bionomics Limited, an Australian clinical-stage biopharmaceutical company founded in 1996 and based in Eastwood, focuses on identifying and developing innovative drug candidates to address central nervous system conditions and various cancers. A significant experimental medicine in their pipeline is BNC210, a negative allosteric modulator targeting the a7 nicotinic acetylcholine receptor. This compound is currently undergoing a Phase 2 clinical trial for social anxiety disorder and a Phase 2b study for post-traumatic stress disorder (PTSD). The company's portfolio also includes BNC101, a monoclonal antibody designed to combat cancer stem cells, which has successfully completed its Phase 1 clinical evaluation. Additionally, Bionomics is advancing BNC105, currently in a Phase 2 clinical trial for refractory colorectal cancer and a Phase 1 trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia.

Bionomics Limited is headquartered in AU.

Bionomics Limited (BNOEF) stock trades at $0.01 with a market capitalization of $8.81M. The stock is valued at a price-to-earnings (P/E) ratio of -0.30, price-to-book of 0.61, price-to-sales of -1.72. Over the past 52 weeks the stock has ranged between $0.00 and $0.06, and currently trades 83.3% below its 52-week high.

On profitability, Bionomics Limited generates a return on equity (ROE) of -113.35%, return on capital employed of -72.57%, an operating margin of 230.73%, a net profit margin of 271.97%.

Official website: www.bionomics.com.au

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides